140 related articles for article (PubMed ID: 27858996)
1. Methotrexate treatment and risk for cutaneous malignant melanoma: a retrospective comparative registry-based cohort study.
Polesie S; Gillstedt M; Sönnergren HH; Osmancevic A; Paoli J
Br J Dermatol; 2017 Jun; 176(6):1492-1499. PubMed ID: 27858996
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment for patients with psoriasis and risk of cutaneous melanoma: a nested case-control study.
Polesie S; Gillstedt M; Paoli J; Osmancevic A
Br J Dermatol; 2020 Oct; 183(4):684-691. PubMed ID: 31981364
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate Exposure and Risk of Cutaneous Malignant Melanoma: No Evidence of a Dose-response Relationship.
Polesie S; Gillstedt M; Paoli J; Osmancevic A
Acta Derm Venereol; 2018 Oct; 98(9):888-895. PubMed ID: 29972216
[TBL] [Abstract][Full Text] [Related]
4. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
[TBL] [Abstract][Full Text] [Related]
5. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
[TBL] [Abstract][Full Text] [Related]
7. Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study.
Lange E; Blizzard L; Venn A; Francis H; Jones G
Rheumatology (Oxford); 2016 Sep; 55(9):1594-600. PubMed ID: 27185957
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.
Varatharajan N; Lim IG; Anandacoomarasamy A; Russo R; Byth K; Spencer DG; Manolios N; Howe GB
Intern Med J; 2009 Apr; 39(4):228-36. PubMed ID: 19402861
[TBL] [Abstract][Full Text] [Related]
9. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
10. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based cohort study.
Polesie S; Gillstedt M; Paoli J; Osmancevic A
J Am Acad Dermatol; 2017 Jul; 77(1):161-163. PubMed ID: 28619553
[No Abstract] [Full Text] [Related]
12. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98.
Nieto A; Ruiz-Ramos M; Abdel-Kader L; Conde M; Camacho F
Br J Dermatol; 2003 Jan; 148(1):110-6. PubMed ID: 12534603
[TBL] [Abstract][Full Text] [Related]
14. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
15. Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.
Leon L; Rodriguez-Rodriguez L; Freites D; Arietti L; Morado I; Vadillo C; Lamas JR; Fernandez B; Jover JA; Abasolo L
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):165-170. PubMed ID: 28134073
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
[TBL] [Abstract][Full Text] [Related]
17. Use of methotrexate and risk of skin cancer: a nationwide case-control study.
Polesie S; Gillstedt M; Schmidt SAJ; Egeberg A; Pottegård A; Kristensen K
Br J Cancer; 2023 Mar; 128(7):1311-1319. PubMed ID: 36739322
[TBL] [Abstract][Full Text] [Related]
18. Effects of Concomitant Methotrexate on Large Joint Replacement in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors: A Multicenter Retrospective Cohort Study in Japan.
Asai S; Kojima T; Oguchi T; Kaneko A; Hirano Y; Yabe Y; Kanayama Y; Takahashi N; Funahashi K; Hanabayashi M; Hirabara S; Yoshioka Y; Takemoto T; Terabe K; Asai N; Ishiguro N
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1363-70. PubMed ID: 25832554
[TBL] [Abstract][Full Text] [Related]
19. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women.
Pérez-Gómez B; Aragonés N; Gustavsson P; Lope V; López-Abente G; Pollán M
Br J Dermatol; 2008 Apr; 158(4):766-72. PubMed ID: 18241261
[TBL] [Abstract][Full Text] [Related]
20. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma.
Damento GM; Pulido JS; Abbott BA; Hodge DO; Dalvin LA
Mayo Clin Proc; 2019 Jul; 94(7):1287-1295. PubMed ID: 31272570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
